Galidesivir

Products Galidesivir is in development at BioCryst in the United States and is not yet commercially available. Structure and properties Galidesivir (C11H15N5O3, Mr = 265.27 g/mol) is a prodrug that is metabolized in cells to the active triphosphate. Galidesivir belongs to the nucleoside analogues. It is a derivative of adenosine, to which it is closely … Galidesivir